View Clinical Trial (Medical Research Study)

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis - NCT00455208-94087(Clinical Trial 167236)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Sunnyvale
State:  
CA
Zip Code: 94087
Conditions: Rheumatoid Arthritis - Osteoarthritis
Purpose: The purpose of the study is to evaluate the safety and efficacy of Cura-100 in treating rheumatoid arthritis and osteoarthritis.
Study summary: This is the Phase I/II trial, which monitors both safety and efficacy of Cura-100 in subjects with rheumatoid arthritis and osteoarthritis at one clinical study center. The open-label clinical study will be used in the study. The study is expected to last for one and a half year after it has been officially started, which include recruitment, study treatment and follow-ups. The healthy volunteers are also included to study the safety of the intervention.
Criteria: Inclusion Criteria: - Having a diagnosis of rheumatoid arthritis and osteoarthritis at active stage - Able and willing to comply with study visits and procedures specified in this protocol for at least six months period - Able to understand and willing to sign and date the written informed consent form prior to admission of the study - Able and willing to provide adequate information for locator purposes - Able and willing to provide self evaluation information and diagnostic report of arthritis as required for efficacy evaluation Exclusion Criteria: - Pregnant women - Over-weighted - Hypertension, or diabetes, or a history of cardiovascular disease or kidney disease, or serious skin allergy or other concurrent clinically significant illness or medical condition (other than arthritis) which, in the viewpoint of the study doctor, may put the subject at a possible risk for participation - Patients used biologic modifier therapy or currently taking immunosuppressive agents might be excluded - Unable to spend 3 hours for treatment at the study center
Study is available at: Cura Biotech LLC
Sunnyvale, CA 94087
United States
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.